71 related articles for article (PubMed ID: 10908013)
1. Methamphetamine and cocaine users: differences in characteristics and treatment retention.
Rawson R; Huber A; Brethen P; Obert J; Gulati V; Shoptaw S; Ling W
J Psychoactive Drugs; 2000; 32(2):233-8. PubMed ID: 10908013
[TBL] [Abstract][Full Text] [Related]
2. Classical stimulants in Dallas County: A retrospective review of toxicological, seized drug, and demographical data from 2017 to 2022.
Glicksberg L; Casey BK; Dempsey SK
J Forensic Sci; 2023 Nov; 68(6):2093-2102. PubMed ID: 37650474
[TBL] [Abstract][Full Text] [Related]
3. Age of Onset and Its Related Factors in Cocaine or Methamphetamine Use in Adults from the United States: Results from NHANES 2005-2018.
Guerin AA; Kim JH
Int J Environ Res Public Health; 2021 Nov; 18(22):. PubMed ID: 34832019
[TBL] [Abstract][Full Text] [Related]
4. Illusory predictors: Generalizability of findings in cocaine treatment retention research.
Stotts AL; Mooney ME; Sayre SL; Novy M; Schmitz JM; Grabowski J
Addict Behav; 2007 Dec; 32(12):2819-36. PubMed ID: 17543472
[TBL] [Abstract][Full Text] [Related]
5. Treating Alcohol Problems in the Context of Other Drug Abuse.
Miller WR; Bennett ME
Alcohol Health Res World; 1996; 20(2):118-123. PubMed ID: 31798097
[TBL] [Abstract][Full Text] [Related]
6. Virtual contingency management, what is it worth and who will pay for it?
McKetin R; Clay S
Addiction; 2024 May; ():. PubMed ID: 38752258
[No Abstract] [Full Text] [Related]
7. Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects.
Newton TF; De La Garza R; Kalechstein AD; Nestor L
Pharmacol Biochem Behav; 2005 Sep; 82(1):90-7. PubMed ID: 16112720
[TBL] [Abstract][Full Text] [Related]
8. Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice.
Denning CJE; Madory LE; Herbert JN; Cabrera RA; Szumlinski KK
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339206
[TBL] [Abstract][Full Text] [Related]
9. Housing Instability Associated with Return to Stimulant Use among Previously Abstaining Women.
Mehtani NJ; Chuku CC; Meacham MC; Vittinghoff E; Dilworth SE; Riley ED
Int J Environ Res Public Health; 2023 Sep; 20(19):. PubMed ID: 37835100
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Regulatory Dynamics in Models of Methamphetamine-Use Disorder.
Jayanthi S; McCoy MT; Cadet JL
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681009
[TBL] [Abstract][Full Text] [Related]
11. Long-term functioning to provide empirical support for the clinical relevance of treatment outcomes for methamphetamine use disorders.
Miguel AQC; Smith CL; Burduli E; Roll JM; McPherson S
J Subst Abuse Treat; 2021 May; 124():108291. PubMed ID: 33771286
[TBL] [Abstract][Full Text] [Related]
12. Combining respondent-driven sampling with a community-based participatory action study of people who smoke drugs in two cities in British Columbia, Canada.
Elkhalifa S; Jozaghi E; Marsh S; Thomson E; Gregg D; Buxton J; Jolly A
Harm Reduct J; 2021 Mar; 18(1):37. PubMed ID: 33771164
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of synthetic psychoactive cathinones and amphetamine stimulants on the gut microbiome in mice.
Angoa-Pérez M; Zagorac B; Winters AD; Greenberg JM; Ahmad M; Theis KR; Kuhn DM
PLoS One; 2020; 15(1):e0227774. PubMed ID: 31978078
[TBL] [Abstract][Full Text] [Related]
14. Cocaine-Induced Psychosis and Asenapine as Treatment: A Case Study.
Palma-Álvarez RF; Ros-Cucurull E; Ramos-Quiroga JA; Roncero C; Grau-López L
Psychopharmacol Bull; 2019 Feb; 49(1):92-97. PubMed ID: 30858643
[TBL] [Abstract][Full Text] [Related]
15. A Mouse Model for Binge-Level Methamphetamine Use.
Shabani S; Houlton SK; Hellmuth L; Mojica E; Mootz JR; Zhu Z; Reed C; Phillips TJ
Front Neurosci; 2016; 10():493. PubMed ID: 27853417
[TBL] [Abstract][Full Text] [Related]
16. Abnormal fronto-limbic engagement in incarcerated stimulant users during moral processing.
Fede SJ; Harenski CL; Schaich Borg J; Sinnott-Armstrong W; Rao V; Caldwell BM; Nyalakanti PK; Koenigs MR; Decety J; Calhoun VD; Kiehl KA
Psychopharmacology (Berl); 2016 Sep; 233(17):3077-87. PubMed ID: 27401337
[TBL] [Abstract][Full Text] [Related]
17. Course of Psychiatric Symptoms and Abstinence among Methamphetamine-Dependent Persons in Sober Living Recovery Homes.
Polcin DL; Witbrodt J; Korcha R; Gupta S; Mericle AA
J Psychoactive Drugs; 2016; 48(3):173-80. PubMed ID: 27184803
[TBL] [Abstract][Full Text] [Related]
18. Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs.
Monteiro JF; Escudero DJ; Weinreb C; Flanigan T; Galea S; Friedman SR; Marshall BD
Epidemiol Infect; 2016 Jun; 144(8):1683-700. PubMed ID: 26753627
[TBL] [Abstract][Full Text] [Related]
19. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
